加载中
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
常规交易时段
US$1.075
−US$0.155 · -12.60%
盘中时间采用ET。市场数据可能有所延迟。
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
日内区间
当前US$1.075
52周区间
当前US$1.075
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
卖出
估值
8
估值过高
情绪
54
多空交织
风险
63
高风险
动量
30
动能减弱
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
日内区间
当前US$1.075
52周区间
当前US$1.075
营业利润
净利润
| 项目（USD） | 2024财年 | 2023财年 | 2022财年 | 2021财年 | 2020财年 |
|---|---|---|---|---|---|
| 销货成本 | 12.91万 USD | — | — | — | 39.14万 USD |
| 毛利 | −12.91万 USD | — | — | — | −39.14万 USD |
| 研究与开发 | 53.74万 USD | 270.88万 USD | 416.52万 USD | 837.28万 USD | 1553.81万 USD |
| 销售、一般及管理费用 | 1788.01万 USD | 2455.76万 USD | 1531.82万 USD | 1432.98万 USD | 747.22万 USD |
| 营业费用 | 1841.75万 USD | 8163.93万 USD | 3855.69万 USD | 1.16亿 USD | 2301.04万 USD |
| 利息收入 | 11.63万 USD | — | — | 12.2万 USD | 1.32万 USD |
| 利息支出 | 72.57万 USD | 243.48万 USD | 70.7万 USD | 37.28万 USD | 37.96万 USD |
| 折旧和摊销 | 12.91万 USD | 12.19万 USD | 11.35万 USD | 12.36万 USD | 39.14万 USD |
| 营业利润 | −1854.66万 USD | −8163.93万 USD | −3855.69万 USD | −1.16亿 USD | −2340.18万 USD |
| 净利润 | −1.78亿 USD | −8842.58万 USD | −3968.41万 USD | −1.13亿 USD | −2672.36万 USD |
公司数据更新于 2026年10月12日。
报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
